BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26643285)

  • 1. Ventricular Tachycardia Ablation in the Presence of Left Ventricular Thrombus: Safety and Efficacy.
    Rao HB; Yu R; Chitnis N; DO D; Boyle NG; Shivkumar K; Bradfield JS
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):453-9. PubMed ID: 26643285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial only mapping and ablation of ventricular tachycardia: a case series.
    Berte B; Yamashita S; Sacher F; Cochet H; Hooks D; Aljefairi N; Amraoui S; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
    Europace; 2016 Feb; 18(2):267-73. PubMed ID: 25840285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
    Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality?
    Dinov B; Arya A; Schratter A; Schirripa V; Fiedler L; Sommer P; Bollmann A; Rolf S; Piorkowski C; Hindricks G
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):598-605. PubMed ID: 25873719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of catheter ablation of ventricular tachycardia: a single-center experience.
    Peichl P; Wichterle D; Pavlu L; Cihak R; Aldhoon B; Kautzner J
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):684-90. PubMed ID: 24958396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter Ablation of Ventricular Tachycardia in the Presence of an Old Endocavitary Thrombus Guided by Intracardiac Echocardiography.
    Peichl P; Wichterle D; Čihák R; Aldhoon B; Kautzner J
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):581-7. PubMed ID: 26969894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease.
    Izquierdo M; Sánchez-Gómez JM; Ferrero de Loma-Osorio A; Martínez A; Bellver A; Peláez A; Núñez J; Núñez C; Chorro J; Ruiz-Granell R
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):882-9. PubMed ID: 26056239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig ventricular tachycardia registry.
    Dinov B; Arya A; Bertagnolli L; Schirripa V; Schoene K; Sommer P; Bollmann A; Rolf S; Hindricks G
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1144-51. PubMed ID: 25262159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.
    Dinov B; Fiedler L; Schönbauer R; Bollmann A; Rolf S; Piorkowski C; Hindricks G; Arya A
    Circulation; 2014 Feb; 129(7):728-36. PubMed ID: 24211823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.